My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

4.490 -0.040 (-0.88%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Myriad Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023 ↗

May 23, 2023

Via Benzinga

Lilium, Myriad Genetics And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

May 23, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Where Myriad Genetics Stands With Analysts ↗

May 04, 2023

Via Benzinga

The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗

March 25, 2023

Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.

Via InvestorPlace

3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

March 01, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Earnings Preview For Myriad Genetics ↗

February 27, 2023

Via Benzinga

Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 05, 2023

Gainers

Via Benzinga

3 Gene Editing Stocks With the Best Long-Term Potential ↗

January 25, 2023

These gene editing stocks are likely to deliver massive gains ahead in the fast-evolving biotech space

Via InvestorPlace

Myriad Genetics Q3 Earnings Fall Short Of Expectations, Lowers Annual Outlook ↗

November 01, 2022

Via Benzinga

Analyst Initiates Coverage On This Genetic Testing Stock With Ongoing Transformation ↗

October 06, 2022

Via Benzinga

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 01, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Via Benzinga

Insiders Selling DocuSign, Adobe And 2 Other Stocks ↗

January 24, 2023

The Nasdaq settled higher by 2% on Monday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Raymond James Upgrades Natera & Myriad Genetics, While Downgrading This Stock ↗

January 18, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023 ↗

January 18, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 30, 2022

Friday's session saw 75 companies set new 52-week lows.

Via Benzinga

Why Shares of Myriad Genetics Dropped 24% This Week ↗

November 03, 2022

The genetic-testing company announced an acquisition and lowered its guidance.

Via The Motley Fool

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast ↗

November 01, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 70 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 01, 2022

Gainers

Via Benzinga

Dow Drops Over 200 Points; Crude Oil Rises Sharply ↗

November 01, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

November 01, 2022

On Tuesday, 85 stocks hit new 52-week lows.

Via Benzinga

Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗

November 01, 2022

Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.

Via Benzinga

Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday ↗

November 01, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Myriad Genetics: Q3 Earnings Insights ↗

November 01, 2022

Myriad Genetics (NASDAQ:MYGN) reported its Q3 earnings results on Tuesday, November 1, 2022 at 09:05 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Preview: Myriad Genetics ↗

October 31, 2022

Myriad Genetics (NASDAQ:MYGN) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that Myriad...

Via Benzinga

Precision Medicine Could Get Even More Precise With Allarity Therapeutics' "Next-Generation" Diagnostics Platform ↗

October 17, 2022

Allarity Therapeutics Inc. (NASDAQ: ALLR) is a clinical-stage pharmaceutical company focused on oncology treatments.

Via Benzinga

Can Artificial Intelligence Predict Our Future Health? ↗

July 05, 2022

Thousands of financial investors and Wall Street pundits advise people daily about what economic trends are coming, what stocks are hot and what is on the upswing. Those same investors and banks...

Via Benzinga

Earnings Scheduled For November 1, 2022 ↗

November 01, 2022

Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022 ↗

October 06, 2022

Upgrades

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.